What is CJC-1295?
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is researched for its ability to stimulate the body's own production of growth hormone, and is frequently discussed alongside GH secretagogues.
Also known as: Modified GRF 1-29, DAC:GRF
How CJC-1295 is studied
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It stimulates the pituitary to release the body's own growth hormone in a more sustained way, and is often researched together with a ghrelin-type secretagogue for a more pulsatile release pattern.
Commonly researched for
Typically stacked with
Research status
Important considerations
Affects the endocrine system. Research use only in most regions.
CJC-1295 — frequently asked questions
Increasing the body's own growth-hormone output, with downstream interest in body composition, recovery, and sleep.
No. Rather than supplying growth hormone directly, it prompts your pituitary to release more of its own. It affects the endocrine system and is research-use in most regions.
It is commonly studied with Ipamorelin. Selpho provides no dosing — endocrine-active compounds should only be considered under medical supervision.